Search research articles
Contact Us
Filters
Showing results (221-230 of 233) with videos related to
Page
of 24
Sort By:
Novartis Foundation Symposium
|
July 8, 2005
Natural genetic variants influencing type 1 diabetes in humans and in the NOD mouse
Linda S Wicker, Carolyn L Moule, Heather Fraser, et al.
Communications Biology
|
October 15, 2021
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
Lorna B Jarvis, Daniel B Rainbow, Valerie Coppard, et al.
Diabetes
|
February 25, 2014
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes
Ricardo C Ferreira, Hui Guo, Richard M R Coulson, et al.
Nucleic Acids Research
|
December 16, 2006
T1DBase: integration and presentation of complex data for type 1 diabetes research
Erin M Hulbert, Luc J Smink, Ellen C Adlem, et al.
Nature Genetics
|
February 6, 2007
Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity
Jun Yamanouchi, Dan Rainbow, Pau Serra, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 27, 2011
Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice
Daniel B Rainbow, Carolyn Moule, Heather I Fraser, et al.
JCI Insight
|
August 18, 2017
Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2
Marcin L Pekalski, Arcadio Rubio García, Ricardo C Ferreira, et al.
Genome Biology
|
September 6, 2017
Chromosome contacts in activated T cells identify autoimmune disease candidate genes
Oliver S Burren, Arcadio Rubio García, Biola-Maria Javierre, et al.
BMC Genetics
|
February 22, 2005
Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes
Lisa M Maier, Deborah J Smyth, Adrian Vella, et al.
Plos Medicine
|
October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
John A Todd, Marina Evangelou, Antony J Cutler, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 233) with videos related to
Sort By:
Page
of 24
Novartis Foundation Symposium
|
July 8, 2005
Natural genetic variants influencing type 1 diabetes in humans and in the NOD mouse
Linda S Wicker, Carolyn L Moule, Heather Fraser, et al.
Communications Biology
|
October 15, 2021
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
Lorna B Jarvis, Daniel B Rainbow, Valerie Coppard, et al.
Diabetes
|
February 25, 2014
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes
Ricardo C Ferreira, Hui Guo, Richard M R Coulson, et al.
Nucleic Acids Research
|
December 16, 2006
T1DBase: integration and presentation of complex data for type 1 diabetes research
Erin M Hulbert, Luc J Smink, Ellen C Adlem, et al.
Nature Genetics
|
February 6, 2007
Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity
Jun Yamanouchi, Dan Rainbow, Pau Serra, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 27, 2011
Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice
Daniel B Rainbow, Carolyn Moule, Heather I Fraser, et al.
JCI Insight
|
August 18, 2017
Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2
Marcin L Pekalski, Arcadio Rubio García, Ricardo C Ferreira, et al.
Genome Biology
|
September 6, 2017
Chromosome contacts in activated T cells identify autoimmune disease candidate genes
Oliver S Burren, Arcadio Rubio García, Biola-Maria Javierre, et al.
BMC Genetics
|
February 22, 2005
Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes
Lisa M Maier, Deborah J Smyth, Adrian Vella, et al.
Plos Medicine
|
October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
John A Todd, Marina Evangelou, Antony J Cutler, et al.
Page
of 24